Eichler C, Najafpour M, Sauerwald A, Puppe J, Warm M
Breast Cancer Center, Municipal Hospital Holweide, 51067 Cologne, Germany ; Department of Gynecology and Obstetrics, Municipal Hospital Holweide, 51067 Cologne, Germany.
Department of Gynecology and Obstetrics, Helios Klinikum, 53721 Siegburg, Germany.
Biomed Res Int. 2015;2015:630601. doi: 10.1155/2015/630601. Epub 2015 Mar 24.
Platelet-rich plasma (PRP) is a product widely used in sports medicine, tissue repair, and general surgery. A recent meta-analysis showed this product to be beneficial when introduced into a wound area, be it intra-articular (i.e., joint-injections) or direct introduction onto the wound surface.
Between the years of 2012 and 2014 a questionnaire evaluating surgical outcome after port (venous access device) removal was answered by 100 patients in the control group and 20 patients in a PRP group, leading to a total of 120 patients in this single center, retrospective, subjective outcome evaluation.
No statistical difference was shown in postsurgical complication rates, postsurgical pain, decreased mobility, and overall quality of life. A significant difference was shown in overall patient satisfaction and the desire to further improve port area scarring. Results differed significantly in favor of the PRP group. Interestingly, approximately 40.2% of patients are dissatisfied with the surgical outcome after port removal in the control group. This result, though surprising, may be improved to 10% dissatisfaction when a PRP product is used.
PRP products such as Arthrex ACP are safe to use and present an additional option in improving surgical outcome.
富血小板血浆（PRP）是一种广泛应用于运动医学、组织修复和普通外科的产品。最近的一项荟萃分析表明，将该产品引入伤口区域（无论是关节内，即关节注射，还是直接引入伤口表面）是有益的。
在2012年至2014年期间，100名对照组患者和20名PRP组患者回答了一份关于端口（静脉通路装置）移除后手术结果的问卷，在这个单中心、回顾性、主观结果评估中，共有120名患者参与。
术后并发症发生率、术后疼痛、活动能力下降和总体生活质量方面未显示出统计学差异。在总体患者满意度和改善端口区域瘢痕的意愿方面显示出显著差异。结果明显有利于PRP组。有趣的是，对照组中约40.2%的患者对端口移除后的手术结果不满意。这一结果虽然令人惊讶，但使用PRP产品时，不满意率可能会降至10%。
Arthrex ACP等PRP产品使用安全，为改善手术结果提供了额外选择。
